Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

Status Recruiting

Clinical Trial Summary

Nocturnal Enuresis (NE) is defined as the involuntary passage of urine during sleep past the age of usual control, which is considered a developmental age of 5 to 7 years. NE is a common problem that causes distress to both children and their families. It has an adverse impact on behavior and social life, affects self-esteem, and can result in poor emotional well-being. In Egypt, the prevalence of NE in primary school children is about 15.4%. The family history was seen to have had a markedly significant impact on the occurrence of NE in the studied children. The mainstay of treatment is urotherapy with information and psychoeducation about normal lower urinary tract function, the underlying cause of MNE, disturbed bladder dysfunction in the child with NMNE, and instructions about therapeutic strategies. Alarm therapy and desmopressin are effective in randomized trials. Children with NMNE first need treatment of the underlying daytime functional bladder problem before treatment of nocturnal enuresis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06285006
Study type	Interventional
Source	Al-Azhar University
Contact	Omnia Nassar, Dr
Phone	01010112054
Email	omnianassar835@gmail.com
Status	Recruiting
Phase	N/A
Start date	February 23, 2024
Completion date	May 12, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02600676` - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis	N/A
Completed	`NCT04191863` - Sleep Architecture in Valproate-induced Nocturnal Enuresis in Primary School and Preschool Children.
Recruiting	`NCT03199508` - Clinical Values of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children	N/A
Enrolling by invitation	`NCT05710718` - PureWick™ France and U.S. At-Home Pilot Study	N/A
Recruiting	`NCT06135311` - Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children	N/A
Completed	`NCT03047720` - Scheduled Awakenings for the Treatment of Nocturnal Enuresis	N/A
Recruiting	`NCT05617664` - Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis	N/A
Completed	`NCT02328092` - A Double-blind Randomized Clinical Trial on the Efficacy of Magnetic Sacral Roots Stimulation for the Treatment of NE	N/A
Completed	`NCT02068560` - The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion	N/A
Withdrawn	`NCT02337413` - Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis	Phase 4
Completed	`NCT01368913` - MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis	N/A
Terminated	`NCT04420585` - Desmopressin for Bedwetting in Children With SCD	Phase 4
Completed	`NCT02538302` - Minirin Versus Oxybutynin for Nocturnal Enuresis in Children	Phase 3
Recruiting	`NCT04676139` - The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in Children	Phase 3
Completed	`NCT03812094` - Basic Bladder Advice and Alarm Therapy in Nocturnal Enuresis	N/A
Recruiting	`NCT03477812` - Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study
Completed	`NCT02178826` - Nocturnal Enuresis and Rapid Maxillary Expansion	N/A
Recruiting	`NCT01575678` - The Effect of Melatonin on Nocturnal Enuresis	Phase 2
Completed	`NCT01078753` - Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis	Phase 3
Recruiting	`NCT04313192` - TENS Treatment for Bedwetting	N/A